About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Patient Satisfaction Survey (PSS) In Breast Clinic | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT03962595

Patient Satisfaction Survey (PSS) In Breast Clinic

Patient satisfaction is the primary means of assessing the effectiveness of primary health care delivery. It helps in improving the quality of care by identifying and help resolving the potential prob...

Lead sponsor: Tata Memorial Centre•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Tata Memorial Centre

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Women with histological confirmation of breast cancer.
•2. Planned to receive multi-disciplinary curative active cancer directed treatment.
•3. Aware of their diagnosis and treatment plan.
•4. Willingness to participate in study.
•5. Patient able to read and comprehend Hindi and Marathi. -

Exclusion Criteria

•1. Eastern Cooperative Oncology Group 4
•2. Unable to read and fill the questionnaire -

Related studies

HER2-PET: Predicting T-DXd Efficacy and HER2 Heterogeneity

NCT07586215 · Breast Cancer Metastatic

RC48-ADC in HER2-low Advanced Breast Cancer

NCT05831878 · Advanced Breast Cancer

RECRUITINGPhase 2

To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer

NCT07368998 · Breast Cancer

RECRUITINGPhase 2

Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer

NCT06525766 · Anatomic Stage IV Breast Cancer AJCC v8, Estrogen-receptor-positive Breast Cancer, and more

RECRUITINGPhase 4

A Randomized, Self-controlled Post-marketing Clinical Study on the Comparison of Shengbai Oral Liquid and Leucogen Tablets in the Treatment of Moderate Neutropenia Caused by Anti-tumor Drugs in Breast Cancer Patients

NCT07578064 · Breast Cancer, Bone Marrow Suppression

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 10, 2025Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment340

Start dateJan 2017

Last updatedApr 10, 2025

Condition

Locations shown

Tata Memorial Centre

Mumbai, Maharashtra

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 10, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions